AntiCancer, Inc.

26 articles about AntiCancer, Inc.

• AntiCancer Inc. Has Received a New Patent That Revolutionizes Individualized Mouse Models of Human Cancer Patients by Increasing the Patient-tumor Establishment Rate in Mice to Close to 100%

  1/29/2024

  AntiCancer Inc. announced it has just received US Patent 11,871,731 that describes a method to increase the rate of establishment of patient tumors in mice to close to 100%.

• AntiCancer’s PDOX Mouse Model Has Demonstrated High Clinical Concordance Which Will Enable Precise Individualized Chemotherapy of Cancer Patients

  10/2/2023

  AntiCancer Inc. of San Diego has announced its PDOX mouse model of human cancer patients has demonstrated high concordance of chemotherapy in the mouse and patient.

• AntiCancer Inc. Scientists Discover the Fundamental Basis of the Malignancy of Cancer

  4/6/2022

  In a new article appearing in the current issue of the Cell Press scientific journal iScience, AntiCancer Inc. of San Diego has demonstrated that the addiction of cancer to the common amino acid methionine is the basis of the malignancy of cancer.

• Patent Allowed for AntiCancer Inc.’s Oral Methioninase Which Targets Cancer, Covid-19, Diabetes, Obesity and Aging

  3/29/2021

  AntiCancer Inc. announces that its patent application on oral methioninase has been allowed by the United States Patent and Trademark Office.

• AntiCancer Files Second Lawsuit Against Certis Oncology

  10/19/2020

  AntiCancer, Inc., a worldwide leader in cancer research and the pioneer of patient-derived mouse models of cancer, announced today it has filed a second lawsuit against Certis Oncology Solutions, Inc. The companies are locked in a long-running legal dispute over hundreds of “immortalized” patient tumor samples which AntiCancer developed and alleges were stolen by Certis, a controversial startup which was originally founde

• AntiCancer Inc. Establishes Subsidiary CoronaCure to Develop Its Novel Therapeutic for COVID-19

  4/22/2020

  AntiCancer Inc. has announced that it has established a fully owned subsidiary company, CoronaCure LLC, in order to develop its novel therapeutic for COVID-19..

• No More Need for Dieting? AntiCancer’s Oral Methioninase Prevents Mouse Obesity and Diabetes on an Ultra-high-fat Diet

  3/10/2020

  AntiCancer Inc. has announced that its methionine-cleaving enzyme methioninase prevented mice from becoming obese while on an ultra-high fat diet.

• AntiCancer Inc. to Target Its Oral Recombinant Methioninase Against 2019-nCoV Coronavirus

  2/3/2020

  Currently there are no therapies or vaccines for patients infected with 2019-nCoV coronavirus around the world.

• AntiCancer Inc prevails in Federal Court over Certis Oncology's attempt to dismiss AntiCancer's $28 million lawsuit

  11/5/2018

  On November 1, the Federal Court of the Southern District of California, denied Certis motion to dismiss AntiCancer's $28.1 million lawsuit against them.

• AntiCancer Invents New Method to Implant Patient Tumors in Mice Resulting in Almost a 100% Establishment Rate with the Goal of Individualizing Therapy for Every Cancer Patient

  8/6/2018

  AntiCancer, Inc. has made a major breakthrough to increase the establishment rate of patient tumors in mouse models.

• AntiCancer’s Oral Methioninase Overcomes Gemcitabine Resistance in Patient-Like Mouse Models of Pancreatic Cancer

  6/25/2018

  The new results are to be published in the upcoming issue of Cancer Letters.

• AntiCancer Inc. Has Developed a Methuselah Enzyme Taken Orally That Hopefully Extends Normal Lifespan and Also Arrests Cancer

  1/8/2018

  The common amino-acid methionine, present in all proteins, is a culprit in the aging process as well as in cancer.

• AntiCancer And Japanese Scientists Make Beating Heart-Muscle Tissue Sheets From Hair Follicle Stem Cells

  4/5/2016

• AntiCancer Announces It Has Rejuvenated Aged Hair Follicles

  3/22/2016

• AntiCancer Announces Extensive Hair Growth After Transplantation Of Cryopreserved Hair Follicles

  1/4/2016

• AntiCancer Announces New Technology For Growing Hair In Long-Term Culture

  10/1/2015

• AntiCancer Announces Extensive Hair Growth From The Spinal Cord Of Mice Transplanted With Pluripotent Hair Follicle Stem Cells For Repair

  8/6/2015

• AntiCancer Announces New Fluorescence Technology Developed For Curative Pancreatic Cancer Surgery

  6/24/2014

• AntiCancer Reports Peripheral Nerve Growth in Culture From Stem Cells

  7/15/2013

• AntiCancer And Okayama University Develops New Gene-Based Fluorescence-Labeling Technology for Cancer Surgery

  8/19/2009